Literature DB >> 22072257

Association between endolymphatic hydrops as revealed by magnetic resonance imaging and caloric response.

Masahiro Kato1, Masaaki Teranishi, Naomi Katayama, Michihiko Sone, Shinji Naganawa, Tsutomu Nakashima.   

Abstract

OBJECTIVE: To investigate the association between the degree of endolymphatic hydrops (EH) revealed by magnetic resonance imaging (MRI) and a caloric response in the ear. STUDY
DESIGN: Prospective diagnostic study.
SETTING: University hospital. PATIENTS: Twenty-four patients with hearing loss and/or vertigo, who underwent MRI 1 day after an intratympanic gadolinium injection. INTERVENTION: MRI after intratympanic gadolinium injection and caloric testing with cool air stimulation (15°C, 6 l/min, 60 s). MAIN OUTCOME MEASURE: Association between the degree of EH and caloric responses. The degree of EH in the vestibule, in the cochlea, and in the ampulla of the lateral semicircular canal (LSC) was evaluated using MRI. The ratio of the diameter of the endolymphatic space to the diameter of the perilymphatic space was measured in the LSC ampulla.
RESULTS: Canal paresis (CP, >25%) was present in 15 patients and absent (CP, <25%) in 9 patients. There was no significant difference between caloric response and the degree of EH in the vestibule, the cochlea, or the LSC ampulla. The period between the onset of clinical symptoms and examination tended to be longer in the group with CP compared with the group without CP.
CONCLUSION: There was no significant association between the degree of EH and caloric response.

Entities:  

Mesh:

Year:  2011        PMID: 22072257     DOI: 10.1097/MAO.0b013e318235568d

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  8 in total

1.  MR volumetric assessment of endolymphatic hydrops.

Authors:  R Gürkov; A Berman; O Dietrich; W Flatz; C Jerin; E Krause; D Keeser; B Ertl-Wagner
Journal:  Eur Radiol       Date:  2014-10-16       Impact factor: 5.315

Review 2.  Visualization of endolymphatic hydrops with MR imaging in patients with Ménière's disease and related pathologies: current status of its methods and clinical significance.

Authors:  Shinji Naganawa; Tsutomu Nakashima
Journal:  Jpn J Radiol       Date:  2014-02-06       Impact factor: 2.374

3.  Effect of standard-dose Betahistine on endolymphatic hydrops: an MRI pilot study.

Authors:  R Gürkov; W Flatz; D Keeser; M Strupp; B Ertl-Wagner; E Krause
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-04       Impact factor: 2.503

4.  Endolymphatic hydrops in patients with tinnitus as the major symptom.

Authors:  Tadao Yoshida; Masaaki Teranishi; Masahiro Kato; Hironao Otake; Ken Kato; Michihiko Sone; Masahiro Yamazaki; Shinji Naganawa; Tsutomu Nakashima
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-02-06       Impact factor: 2.503

5.  Intravenous Delayed Gadolinium-Enhanced MR Imaging of the Endolymphatic Space: A Methodological Comparative Study.

Authors:  Rainer Boegle; Johannes Gerb; Emilie Kierig; Sandra Becker-Bense; Birgit Ertl-Wagner; Marianne Dieterich; Valerie Kirsch
Journal:  Front Neurol       Date:  2021-04-22       Impact factor: 4.003

6.  Usefulness of Intravenous Gadolinium Inner Ear MR Imaging in Diagnosis of Ménière's Disease.

Authors:  Young Sang Cho; Jung Min Ahn; Ji Eun Choi; Hyun Woo Park; Yi-Kyung Kim; Hyung-Jin Kim; Won-Ho Chung
Journal:  Sci Rep       Date:  2018-12-03       Impact factor: 4.379

7.  Vestibular Endolymphatic Hydrops Visualized by Magnetic Resonance Imaging and Its Correlation With Vestibular Functional Test in Patients With Unilateral Meniere's Disease.

Authors:  Yupeng Liu; Fan Zhang; Baihui He; Jingchun He; Qing Zhang; Jun Yang; Maoli Duan
Journal:  Front Surg       Date:  2021-06-04

8.  Morphological correlation between caloric tests and vestibular hydrops in Ménière's disease using intravenous Gd enhanced inner ear MRI.

Authors:  Ji Eun Choi; Yi-Kyung Kim; Young Sang Cho; Kieun Lee; Hyun Woo Park; Sung Hoon Yoon; Hyung-Jin Kim; Won-Ho Chung
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.